跳至主要内容
临床试验/NCT01439178
NCT01439178Unknown不适用

Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab

Seoul St. Mary's Hospital1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2011年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
28
试验地点
1
主要终点
intraocular VEGF levels (pg/ml) in both groups (measured in aqueous humor), using multiplex beads immunoassay

研究概览

简要总结

Purpose: To evaluate the acute changes in intraocular cytokines after intravitreal bevacizumab (IVB) in proliferative diabetic retinopathy.

Design: Prospective, open-label, controlled, randomized interventional clinical trial.

Participants: Twenty eyes of 28 consecutive patients who are scheduled for pars plana vitrectomy (ppV) for proliferative diabetic retinopathy were prospectively enrolled.

Methods: All patients were randomly assigned to receive IVB either at 2 or 7 days before ppV. Aqueous humor samples were taken from anterior chamber just before IVB and at the time of surgery. Multiplex cytokine array were used to assay various cytokines

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with proliferative diabetic retinopathy who were scheduled for PPV for vitreous hemorrhage or tractional retinal detachment (TRD)

排除标准

  • Eyes with any pharmacologic intervention on study eye within 6 months
  • Eyes with panretinal photocoagulation on study eye within 3 months
  • Eyes with any pharmacologic intervention on fellow eye within 3 months,
  • History of ocular diseases other than diabetic retinopathy
  • History of PPV on study eye
  • History of systemic thromboembolic events including myocardial infarction and cerebrovascular accidents.

研究组 & 干预措施

Intravitreal Avastin Day 2

Experimental

randomized to either treatment with preoperative IVB 2 days before PPV (Group A) or 7 days before PPV (Group B).

干预措施: Intravitreal Avastin injection (Drug)

Intravitreal Avastin Day 7

Active Comparator

randomized to either treatment with preoperative IVB 2 days before PPV (Group A) or 7 days before PPV (Group B).

干预措施: Intravitreal Avastin injection (Drug)

结局指标

主要结局

intraocular VEGF levels (pg/ml) in both groups (measured in aqueous humor), using multiplex beads immunoassay

时间窗: At day 2 after IVB in Group 1, day 7 after IVB at group 2.

Because we want to compare the differences between day 2 and day 7, vitrectomy will be performed at day 2 in group 1 and day 7 in group 2. That's why the time frame has two time point

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Won Ki Lee

Preofessor

Seoul St. Mary's Hospital

研究点 (1)

Loading locations...

相似试验